Ketamine variant shows promise in treating social impairments

Take­da is con­tin­u­ing to high­light the un­pre­dictable bur­den of hered­i­tary an­gioede­ma in its “Dis­cov­er HAE” cam­paign, in­cor­po­rat­ing more per­son­al sto­ries and im­agery that re­flect pa­tient

Im­mutep has raised about $53 mil­lion to bankroll its LAG-3 drugs across on­col­o­gy and au­toim­mune dis­eases, giv­ing it a cash run­way to the first quar­ter

Ra­dio­phar­ma com­pa­ny Lan­theus is look­ing to build up its port­fo­lio through a col­lab­o­ra­tion with Per­spec­tive Ther­a­peu­tics. By hand­ing Per­spec­tive $28 mil­lion up­front, Lan­theus has the